| Ident. | Authors (with country if any) | Title |
|---|
| 000010 |
YOUN JU LEE [Corée du Sud] ; So-Young Choi [Corée du Sud] ; Jae H. Yang [Corée du Sud] | NMDA receptor-mediated ERK 1/2 pathway is involved in PFHxS-induced apoptosis of PC12 cells |
| 000027 |
JINGYI MA [Canada] ; L. Stan Leung [Canada] | Deep brain stimulation of the medial septum or nucleus accumbens alleviates psychosis-relevant behavior in ketamine-treated rats |
| 000035 |
Anna Effenberg [Allemagne] ; Alexander Klein [Allemagne] ; Robbin Gibb [Canada] ; Cathy Carroll [Canada] ; Wolfgang Baumgartner [Allemagne] ; Claudia Grothea [Allemagne] ; Andreas Ratzka [Allemagne] | Adult hemiparkinsonian rats do not benefit from tactile stimulation |
| 000083 |
Alexander C. Sutton [États-Unis] ; Wilson Yu [États-Unis] ; Megan E. Calos [États-Unis] ; Lauren E. Mueller [États-Unis] ; Matthew Berk [États-Unis] ; Jenny Shim [États-Unis] ; Eric S. Molho [États-Unis] ; Jonathan M. Brotchie [Canada] ; Peter L. Carlen [Canada] ; Damian S. Shin [États-Unis] | Elevated potassium provides an ionic mechanism for deep brain stimulation in the hemiparkinsonian rat |
| 000086 |
Scott Mackey [États-Unis, Canada] ; YU JING [République populaire de Chine, Canada] ; Joseph Flores [Suède, Canada] ; Katie Dinelle [Canada] ; Doris J. Doudet [Canada] | Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: Behavior, positron emission tomography, immunohistochemistry |
| 000088 |
Lily R. Aleksandrova [Canada] ; Meaghan C. Creed [Canada] ; Paul J. Fletcher [Canada] ; Daniela S. S. Lobo [Canada] ; Clement Hamani [Canada] ; José N. Nobrega [Canada] | Deep brain stimulation of the subthalamic nucleus increases premature responding in a rat gambling task |
| 000165 |
Anne Almey [Canada] ; Edward J. Filardo [États-Unis] ; Teresa A. Milner [États-Unis] ; Wayne G. Brake [Canada] | Estrogen Receptors Are Found in Glia and at Extranuclear Neuronal Sites in the Dorsal Striatum of Female Rats: Evidence for Cholinergic But Not Dopaminergic Colocalization |
| 000226 |
Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill [Canada] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada] | Synergistic Antidyskinetic Effects of Topiramate and Amantadine in Animal Models of Parkinson's Disease |
| 000244 |
C. K. Young [Canada] ; I. Q. Whishaw [Canada] ; B. H. Bland [Canada] | POSTERIOR HYPOTHALAMIC NUCLEUS DEEP BRAIN STIMULATION RESTORES LOCOMOTION IN RATS WITH HALOPERIDOL-INDUCED AKINESIA BUT NOT SKILLED FORELIMB USE IN PELLET REACHING AND LEVER PRESSING |
| 000258 |
JING GUO [République populaire de Chine] ; Jun-Kang Shen [République populaire de Chine] ; LAN WANG [République populaire de Chine] ; LI XIAO [République populaire de Chine] ; Rong-Jun Zhang [République populaire de Chine] ; Wei-Feng Luo [République populaire de Chine] ; Zhi-Gang Gong [République populaire de Chine] ; JING SUN [République populaire de Chine] ; HAN XU [République populaire de Chine] ; Pierre Sirois [Canada] ; KAI LI [République populaire de Chine] | In Vivo Evaluation of Cerebral Transplantation of Resovist-Labeled Bone Marrow Stromal Cells in Parkinson's Disease Rats Using Magnetic Resonance Imaging |
| 000262 |
Andrew R. Brown [Canada] ; Michael C. Antle [Canada] ; BIN HU [Canada] ; G. Campbell Teskey [Canada] | High frequency stimulation of the subthalamic nucleus acutely rescues motor deficits and neocortical movement representations following 6-hydroxydopamine administration in rats |
| 000276 |
Alexander Klein [Canada] ; Darryl C. Gidyk [Canada] ; Alexandra M. Shriner [Canada] ; Keri L. Colwell [Canada] ; Nadine A. Tatton [Canada] ; William G. Tatton [Canada] ; Gerlinde A. Metz [Canada] | Dose-dependent loss of motor function after unilateral medial forebrain bundle rotenone lesion in rats: A cautionary note |
| 000282 |
Jacqueline A. Gleave [Canada] ; Troy H. Farncombe [Canada] ; Chantal Saab [Canada] ; Laurie C. Doering [Canada] | Correlative single photon emission computed tomography imaging of [123I]altropane binding in the rat model of Parkinson's |
| 000329 |
Jon F. Davis [États-Unis] ; Maarten Loos [États-Unis] ; Andrea R. Di Sebastiano [Canada] ; Jennifer L. Brown [États-Unis] ; Michael N. Lehman [États-Unis, Canada] ; Lique M. Coolen [États-Unis, Canada] | Lesions of the Medial Prefrontal Cortex Cause Maladaptive Sexual Behavior in Male Rats |
| 000398 |
Andrew R. Brown [Canada] ; BIN HU [Canada] ; Bryan Kolb [Canada] ; G. Campbell Teskey [Canada] | Acoustic tone or medial geniculate stimulation cue training in the rat is associated with neocortical neuroplasticity and reduced akinesia under haloperidol challenge |
| 000403 |
Alexander Klein [Canada, Allemagne] ; Johanna Wessolleck [Allemagne] ; Anna Papazoglou [Allemagne] ; Gerlinde A. Metz [Canada] ; Guido Nikkhah [Allemagne] | Walking pattern analysis after unilateral 6-OHDA lesion and transplantation of foetal dopaminergic progenitor cells in rats |
| 000404 |
Desirae M. Haluk [Canada] ; Stan B. Floresco [Canada] | Ventral Striatal Dopamine Modulation of Different Forms of Behavioral Flexibility |
| 000473 |
R. J. Grant [Canada] ; L. H. L. Sellings [Canada] ; S. J. Crocker [États-Unis] ; E. Melloni [Italie] ; D. S. Park [Canada] ; P. B. S. Clarke [Canada] | EFFECTS OF CALPAIN INHIBITION ON DOPAMINERGIC MARKERS AND MOTOR FUNCTION FOLLOWING INTRASTRIATAL 6-HYDROXYDOPAMINE ADMINISTRATION IN RATS |
| 000478 |
Vesna Sossi [Canada] ; Katherine Dinelle [Canada] ; Geoffrey J. Topping [Canada] ; James E. Holden [États-Unis] ; Doris Doudet [Canada] ; Michael Schulzer [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Raul De La Fuente-Femandez [Canada] | Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's : an in vivo imaging study |
| 000483 |
C. K. Young [Canada] ; S. J. Koke [Canada] ; Z. H. Kiss [Canada] ; B. H. Bland [Canada] | DEEP BRAIN STIMULATION OF THE POSTERIOR HYPOTHALAMIC NUCLEUS REVERSES AKINESIA IN BILATERALLY 6-HYDROXYDOPAMINE-LESIONED RATS |
| 000492 |
N. M. Jadavji [Canada] ; G. A. Metz [Canada] | BOTH PRE-AND POST-LESION EXPERIENTIAL THERAPY IS BENEFICIAL IN 6-HYDROXYDOPAMINE DOPAMINE-DEPLETED FEMALE RATS |
| 000571 |
K. Mukhida [Canada] ; M. Hong [Canada] ; G. B. Miles [Canada] ; T. Phillips [Canada] ; B. A. Baghbaderani [Canada] ; M. Mcleod [Canada] ; N. Kobayashi [Canada] ; A. Sen [Canada] ; L. A. Behie [Canada] ; R. M. Brownstone [Canada] ; I. Mendez [Canada] | A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats |
| 000595 |
Brian N. Mathur [États-Unis] ; M. Diana Neely [États-Unis] ; Melanie Dyllick-Brenzinger [Canada] ; Anurag Tandon [Canada] ; Ariel Y. Deutch [États-Unis] | Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration |
| 000596 |
Brian N. Mathur [États-Unis] ; M. Diana Neely [États-Unis] ; Melanie Dyllick-Brenzinger [Canada] ; Anurag Tandon [Canada] ; Ariel Y. Deutch [États-Unis] | Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration |
| 000611 |
Michelle R. Ciucci [États-Unis] ; Sean T. Ma [États-Unis] ; Cynthia Fox [États-Unis] ; Jacqueline R. Kane [États-Unis] ; Lorraine O. Ramig [États-Unis] ; Timothy Schallert [États-Unis] | Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol : A preliminary study |
| 000632 |
Jessica M. Castellano [Canada] ; Jody Batrynchuk [Canada] ; Kristine Dolbeare [États-Unis] ; Vaneeta Verma [Canada] ; Amandeep Mann [Canada] ; Kevin J. Skoblenick [Canada] ; Rodney L. Johnson [États-Unis] ; Ram K. Mishra [Canada] | MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats |
| 000633 |
Jessica M. Castellano [Canada] ; Jody Batrynchuk [Canada] ; Kristine Dolbeare [États-Unis] ; Vaneeta Verma [Canada] ; Amandeep Mann [Canada] ; Kevin J. Skoblenick [Canada] ; Rodney L. Johnson [États-Unis] ; Ram K. Mishra [Canada] | MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats |
| 000642 |
A. Y. Alemdar [Canada] ; D. Sadi [Canada] ; V. Mcalister [Canada] ; I. Mendez [Canada] | Intracerebral Co-transplantation of liposomal tacrolimus improves xenograft survival and reduces graft rejection in the hemiparkinsonian rat |
| 000646 |
Vesna Sossi [Canada] ; James E. Holden [États-Unis] ; Geoffrey J. Topping [Canada] ; Marie-Laure Camborde [Canada] ; Rich A. Kornelsen [Canada] ; Siobhan E. Mccormick [Canada] ; Jennifer Greene [Canada] ; Andrei R. Studenov [Canada] ; Thomas J. Ruth [Canada] ; Doris J. Doudet [Canada] | In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD |
| 000647 |
Ivan L. Cepeda [Canada] ; Joseph Flores [Canada] ; Michael L. Cornfeldt [États-Unis] ; John R. O'Kusky [Canada] ; Doris J. Doudet [Canada] | Human retinal pigment epithelial cell implants ameliorate motor deficits in two rat models of parkinson disease |
| 000648 |
D. S. Shin [Canada] ; M. Samoilova [Canada] ; M. Cotic [Canada] ; L. Zhang [Canada] ; J. M. Brotchie [Canada] ; P. L. Carlen [Canada] | High frequency stimulation or elevated K+ depresses neuronal activity in the rat entopeduncular nucleus |
| 000651 |
Elissa M. Strome [Canada] ; Athanasios P. Zis [Canada] ; Doris J. Doudet [Canada] | Electroconvulsive shock enhances striatal dopamine D1 and D3 receptor binding and improves motor performance in 6-OHDA-lesioned rats |
| 000690 |
Martine Saint-Pierre [Canada] ; Marie-Eve Tremblay [Canada] ; Attila Sik [Canada] ; Robert E. Gross [États-Unis] ; Francesca Cicchetti [Canada] | Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats |
| 000695 |
Evelyn F. Field [Canada] ; Gerlinde A. Metz [Canada] ; Sergio M. Pellis [Canada] ; Ian Q. Whishaw [Canada] | Sexually dimorphic postural adjustments during vertical behaviour are altered in a unilateral 6-OHDA rat model of Parkinson's disease |
| 000709 |
Rohita Sharma [Canada] ; Catherine R. Mcmillan [Canada] ; Catherine C. Tenn [Canada] ; Lennard P. Niles [Canada] | Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease |
| 000722 |
Meenal Joshi [Canada] ; Rachel F. Tyndale [Canada] | Induction and recovery time course of rat brain CYP2E1 after nicotine treatment |
| 000731 |
N. M. Jadavji [Canada] ; B. Kolb [Canada] ; G. A. Metz [Canada] | Enriched environment improves motor function in intact and unilateral dopamine-depleted rats |
| 000756 |
Fernanda G. De Souza [Brésil] ; Mayra D. B. Rodrigues [Brésil] ; Sergio Tufik [Brésil] ; José N. Nobrega [Canada] ; Vania D'Almeida [Brésil] | Acute stressor-selective effects on homocysteine metabolism and oxidative stress parameters in female rats |
| 000757 |
Naomi P. Visanji [Canada] ; Mark J. Millan [France] ; Jonathan M. Brotchie [Canada] | Actions at sites other than D3 receptors mediate the effects of BP897 on L-DOPA-induced hyperactivity in monoamine-depleted rats |
| 000758 |
J. Lewis [États-Unis] ; G. Bench [États-Unis] ; O. Myers [États-Unis] ; B. Tinner [Canada] ; W. Staines [Canada] ; E. Barr [États-Unis] ; K. K. Divine [États-Unis] ; W. Barrington [États-Unis] ; J. Karlsson [États-Unis] | Trigeminal uptake and clearance of inhaled manganese chloride in rats and mice |
| 000803 |
Katerina Venderov [Canada] ; Timothy M. Brown [Royaume-Uni] ; Jonathan M. Brotchie [Canada] | Differential effects of endocannabinoids on [3H]-GABA uptake in the rat globus pallidus |
| 000809 |
Véronique Sgambato-Faure [France] ; Virginie Buggia [France] ; Frangois Gilbert [Canada] ; Daniel Levesque [Canada] ; Alim-Louis Benabid [France] ; Francois Berger [France] | Coordinated and spatial upregulation of arc in striatonigral neurons correlates with L-dopa-lnduced behavioral sensitization in dyskinetic rats |
| 000826 |
Tom H. Johnston [Canada] ; Joohyung Lee [Canada] ; Jordi Gomez-Ramirez [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada] | A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease |
| 000853 |
Gerlinde A. Metz [Canada] ; Dionne M. Piecharka [Canada] ; Jeffrey A. Kleim [Canada] ; Ian Q. Whishaw [Canada] | Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease |
| 000861 |
D. J. Doudet [Canada] ; M. L. Cornfeldt [États-Unis] ; C. R. Honey [Canada] ; A. W. Schweikert [États-Unis] ; R. C. Allen [États-Unis] | PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of parkinson's disease |
| 000866 |
Louise Normandin [Canada] ; Linda Ann Beaupre [Canada] ; Fariba Salehi [Canada] ; Annie St.-Pierre [Canada] ; Greg Kennedy [Canada] ; Donna Mergler [Canada] ; Roger F. Butterworth [Canada] ; Suzanne Philippe [Canada] ; Joseph Zayed [Canada] | Manganese distribution in the brain and neurobehavioral changes following inhalation exposure of rats to three chemical forms of manganese |
| 000879 |
Lynsey E. Bartlett [Canada] ; Damaso Sadi [Canada] ; Matthew Lewington [Canada] ; Ivar Mendez [Canada] ; Nicholas M. Boulis ; Charles Y. Liu ; Andres M. Lozano ; Roy A. E. Bakay | Functional improvement with low-dose dopaminergic grafts in hemiparkinsonian rats. Comments |
| 000884 |
Naila Ismayilova [Canada] ; Alan Crossman [Canada] ; Alexei Verkhratsky [Canada] ; Jonathan Brotchie [Canada] | Effects of adenosine A1, dopamine D1 and metabotropic glutamate 5 receptors-modulating agents on locomotion of the reserpinised rats |
| 000886 |
Gregory Dalbo [Canada] ; Fannie St-Gelais [Canada] ; Marc Danik [Canada] ; Sylvain Williams [Canada] ; Mathieu Cotton [Canada] ; Louis-Eric Trudeau [Canada] | Dopamine neurons in culture express VGLUT2 explaining their capacity to release glutamate at synapses in addition to dopamine |
| 000895 |
Kerry B. Goralski [Canada] ; Kenneth W. Renton [Canada] | Brain inflammation enhances 1-methyl-4-phenylpyridinium-evoked neurotoxicity in rats |
| 000938 |
Jackalina Van Kampen [Canada] ; Harold Robertson [Canada] ; Theo Hagg [Canada] ; Robert Drobitch [Canada] | Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease |
| 000959 |
Benoit Melchior [France] ; Véronique Nerriere-Daguin [France] ; David-A. Laplaud [France] ; Séverine Remy [France] ; Sandrine Wiertlewski [France] ; Isabelle Neveu [France] ; Philippe Naveilhan [France] ; Susan O. Meakin [Canada] ; Philippe Brachet [France] | Ectopic expression of the TrkA receptor in adult dopaminergic mesencephalic neurons promotes retrograde axonal NGF transport and NGF-dependent neuroprotection |
| 000988 |
J. Q. Lu [Canada] ; A. J. Stoessl [Canada] | Somatostatin modulates the behavioral effects of dopamine receptor activation in parkinsonian rats |
| 000993 |
Vincenzo Di Matteo [Italie] ; Marisa Cacchio [Italie] ; Camillo Di Giulio [Italie] ; Ennio Esposito [Italie] | Role of serotonin2C receptors in the control of brain dopaminergic function |
| 000A02 |
Z. H. T. Kiss [Canada] ; D. M. Mooney [Canada] ; L. Renaud [Canada] ; B. Hu [Canada] | Neuronal response to local electrical stimulation in rat thalamus: Physiological implications for mechanisms of deep brain stimulation |
| 000A12 |
Kristen J. Armstrong [Canada] ; Lennard P. Niles [Canada] | Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells |
| 000A21 |
Sophie Callier [France, Canada] ; Maryvonne Le Saux [France] ; Anne-Marie Lhiaubet [France] ; Thérèse Di Paolo [Canada] ; William Rostene [France] ; Didier Pelaprat [France] | Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture |
| 000A22 |
Michel Cyr [Canada] ; Frederic Calon [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease |
| 000A25 |
Kim G. C. Hellemans [Canada] ; Yavin Shaham [Canada] ; Mary C. Olmstead [Canada] | Effects of acute and prolonged opiate abstinence on extinction behaviour in rats |
| 000A27 |
G. A. Metz [Canada] ; I. Q. Whishaw [Canada] | Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance |
| 000A42 |
Louise Normandin [Canada] ; Gaétan Carrier [Canada] ; Phillip F. Gardiner [Canada] ; Greg Kennedy [Canada] ; Alan S. Hazell [Canada] ; Donna Mergler [Canada] ; Roger F. Butterworth [Canada] ; Suzanne Philippe [Canada] ; Joseph Zayed [Canada] | Assessment of bioaccumulation, neuropathology, and neurobehavior following subchronic (90 days) inhalation in Sprague-Dawley rats exposed to manganese phosphate |
| 000A83 |
A. Y. Alemdar [Canada] ; K. A. Baker [Canada] ; D. Sadi [Canada] ; V. C. Mcalister [Canada] ; I. Mendez [Canada] | Liposomal tacrolimus administered systemically and within the donor cell suspension improves xenograft survival in hemiparkinsonian rats |
| 000B08 |
A. R. Zahran [Canada] ; N. Simmerman [Canada] ; S. Carrier [Canada] ; P. Vachon [Canada] ; Y. Sato | Erectile dysfunction occurs following substantia nigra lesions in the rat. Commentary |
| 000B14 |
Jun-Xia Xie [République populaire de Chine] ; MING TANG [République populaire de Chine] ; CHUNYI ZHANG [Canada] | Effect of cholecystokinin-8 microinjection into ventral tegmental area on dopamine release in nucleus accumbens of rats: An in vivo voltammetric study |
| 000B56 |
I. Mendez [Canada] ; K. A. Baker [Canada] ; M. Hong [Canada] | Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease |
| 000B57 |
E. F. Field [Canada] ; I. Q. Whishaw [Canada] ; S. M. Pellis [Canada] | Sex differences in catalepsy : evidence for hormone-dependent postural mechanisms in haloperidol-treated rats |
| 000B61 |
S. Miksys [Canada] ; Y. Rao [Canada] ; E. M. Sellers [Canada] ; M. Kwan [Canada] ; D. Mendis [Canada] ; R. F. Tyndale [Canada] | Regional and cellular distribution of CYP2D subfamily members in rat brain |
| 000B62 |
C. R. Honey [Canada] ; M. O. K. Obochi ; HAO SHEN ; P. Margaron ; S. Yip ; J. G. Levy | Reduced xenograft rejection in rat striatum after pretransplant photodynamic therapy of murine neural xenografts |
| 000B78 |
I. Mendez [Canada] ; M. Hong ; S. Smith ; A. Dagher ; J. Desrosiers | Neural transplantation cannula and microinjector system : experimental and clinical experience : Technical note |
| 000B79 |
X. Lu [Canada] ; G. Bing [États-Unis] ; T. Hagg [Canada] | Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats |
| 000B86 |
K. A. Baker [Canada] ; M. Hong [Canada] ; D. Sadi [Canada] ; I. Mendez [Canada] | Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease |
| 000B89 |
Maria C. Yang [Canada] ; Allan J. Mclean [Canada] ; Laurent P. Rivory [Australie] ; David G. Le Couteur [Canada] | Hepafic disposition of neurotoxins and pesticides |
| 000B94 |
C. S. Lee [Canada] ; M. A. Cenci [Suède] ; M. Schulzer [Canada] ; A. Björklund [Suède] | Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease |
| 000B95 |
J. M. Van Kampen [Canada] ; A. J. Stoessl [Canada] | Effects of oligonucleotide antisense to dopamine D1A receptor messenger RNA in a rodent model of levodopa-induced dyskinesia |
| 000C06 |
T. J. Hudzik [États-Unis] ; A. Howell [États-Unis] ; K. Payza [Canada] ; A. J. Cross [États-Unis] | Antiparkinson potential of δ-opioid receptor agonists |
| 000C21 |
J. Gauthier [Canada] ; M. Parent [Canada] ; M. Levesque [Canada] ; A. Parent [Canada] | The axonal arborization of single nigrostriatal neurons in rats |
| 000C23 |
M. C. Evans [États-Unis] ; A. Pradhan [Canada] ; S. Venkatraman [États-Unis] ; W. H. Ojala [États-Unis] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis] | Synthesis and dopamine receptor modulating activity of novel peptidomimetics of L-prolyl-L-leucyl-glycinamide featuring α, α-disubstituted amino acids |
| 000C45 |
D. L. Gelowitz [États-Unis] ; I. A. Paterson [Canada] | Neuronal sparing and behavioral effects of the antiapoptotic drug, (-)deprenyl, following kainic acid administration |
| 000C46 |
H. M. Schipper [Canada] ; L. Bernier [Canada] ; K. Mehindate [Canada] ; D. Frankel [Canada] | Mitochondrial iron sequestration in dopamine-challenged astroglia : Role of heme oxygenase-1 and the permeability transition pore |
| 000C52 |
A. Richter [Allemagne] ; U. Ebert [Allemagne] ; J. N. Nobrega [Canada] ; J. J. Vallbacka [Canada] ; M. Fedrowitz [Allemagne] ; W. Löscher [Allemagne] | Immunohistochemical and neurochemical studies on nigral and striatal functions in the circling (ci) rat, a genetic animal model with spontaneous rotational behavior |
| 000C53 |
G. D. Muir [Canada] ; I. Q. Whishaw [Canada] | Ground reaction forces in locomoting hemi-parkinsonian rats : a definitive test for impairments and compensations |
| 000C57 |
G. Flores [Mexique, Canada] ; J. J. Liang [Mexique, Canada] ; A. Sierra [Mexique] ; D. Martinez-Fong [Mexique] ; R. Quirion [Mexique, Canada] ; J. Aceves [Mexique] ; L. K. Srivastava [Mexique] | Expression of dopamine receptors in the subthalamic nucleus of the rat : Characterization using reverse transcriptase-polymerase chain reaction and autoradiography |
| 000C59 |
T. A. Reader [Canada] ; K. M. Dewar [Canada] | Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum : implications for human Parkinson's disease |
| 000C64 |
E. M. Khalil [États-Unis] ; W. H. Ojala [États-Unis] ; A. Pradhan [Canada] ; V. D. Nair [Canada] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis] | Design, synthesis, and dopamine receptor modulating activity of spiro bicyclic peptidomimetics of L-prolyl-L-leucyl-glycinamide |
| 000C66 |
D. Frankel [Canada] ; H. M. Schipper [Canada] | Cysteamine pretreatment of the astroglial substratum (mitochondrial iron sequestration) enhances PC12 cell vulnerability to oxidative injury |
| 000D10 |
E. G. Campioni [Canada] ; J. N. Nobrega [Canada] ; M. V. Sefton [Canada] | HEMA/MMMA microcapsule implants in hemiparkinsonian rat brain : Biocompatibility assessment using [3H]PK11195 as a marker for gliosis |
| 000D13 |
C. Apostolides [Canada] ; E. Sanford [Canada] ; M. Hong [Canada] ; I. Mendez [Canada] | Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells |
| 000D18 |
V. Mehta [Canada] ; M. Hong [Canada] ; J. Spears [Canada] ; I. Mendez [Canada] | Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor |
| 000D22 |
S. J. Crocker [Canada] ; M. Morelli [Italie] ; N. Wigle [Canada] ; Y. Nakabeppu [Japon] ; G. S. Robertson [Canada] | D1-receptor-related priming is attenuated by antisense-meditated 'knockdown' of fosB expression |
| 000D24 |
C. J. Gibson [Canada] ; D. G. Munoz [Canada] | Chromogranin A inhibits dopamine release from rat striatal slices |
| 000D26 |
H. M. Schipper [Canada] ; R. Vininsky [Canada] ; R. Brull [Canada] ; L. Small [Canada] ; J. R. Brawer [Canada] | Astrocyte mitochondria : A substrate for iron deposition in the aging rat substantia nigra |
| 000D58 |
I. Mendez [Canada] ; M. Hong [Canada] | Reconstruction of the striato-nigro-striatal circuitry by simultaneous double dopaminergic grafts: a tracer study using fluorogold and horseradish peroxidase |
| 000D61 |
A. F. Miranda [Canada] ; R. J. Boegman [Canada] ; R. J. Beninger [Canada] ; K. Jhamandas [Canada] | Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid |
| 000D79 |
I. Q. Whishaw [Canada] ; B. L. K. Coles [Canada] ; S. M. Pellis [Canada] ; E. I. Miklyaeva [Canada] | Impairments and compensation in mouth and limb use in free feeding after unilateral dopamine depletions in a rat analog of human Parkinson's disease |
| 000D84 |
N. Rajakumar [Canada] ; W. Rushlow [Canada] ; B. Rajakumar [Canada] ; C. C. G. Naus [Canada] ; A. J. Stoessl [Canada] ; B. A. Flumerfelt [Canada] | Effects of graft-derived dopaminergic innervation on the target neurons of patch and matrix compartments of the striatum |
| 000D93 |
P. W. Baures [États-Unis] ; W. H. Ojala [États-Unis] ; W. J. Costain [Canada] ; M. C. Ott [Canada] ; A. Pradhan [Canada] ; W. B. Gleason [États-Unis] ; R. K. Mishra [Canada] ; R. L. Johnson [États-Unis] | Design, synthesis, and dopamine receptor modulating activity of diketopiperazine peptidomimetics of L-prolyl-L-leucylglycinamide |
| 000D97 |
K. B. S. Pasumarthi [Canada] ; Y. Jin [Canada] ; P. A. Cattini [Canada] | Cloning of the rat Fibroblast growth factor-2 promoter region and its response to mitogenic stimuli in glioma C6 cells |
| 000E02 |
D. D. Newman [Canada] ; N. Rajakumar ; B. A. Flumerfelt ; A. J. Stoessl [Canada] | A kappa opioid antagonist blocks sensitization in a rodent model of Parkinson's disease |
| 000E10 |
D. J. Martens [Canada] ; I. Q. Whishaw [Canada] ; E. I. Miklyaeva [Canada] ; S. M. Pellis [Canada] | Spatio-temporal impairments in limb and body movements during righting in an hemiparkinsonian rat analogue : relevance to axial apraxia in humans |
| 000E23 |
D. Boismenu [Canada] ; O. Mamer [Canada] ; L. Ste-Marie [Canada] ; L. Vachon [Canada] ; J. Montgomery [Canada] | In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors : Electrospray-MS analysis of intra-striatal microdialysates |
| 000E26 |
E. I. Miklyaeva [Canada] ; I. Q. Whishaw [Canada] | HemiParkinson analogue rats display active support in good limbs versus passive support in bad limbs on a skilled reaching task of variable height |
| 000E34 |
C. V. Borlongan [États-Unis] ; T. B. Freeman ; R. A. Hauser ; D. W. Cahill ; P. R. Sanberg ; R. R. Tasker | Cyclosporine-A increases locomotor activity in rats with 6-hydroxydopamine-induced hemiparkinsonism : Relevance to neural transplantation. Commentary |
| 000E40 |
B. P. Connop [Canada] ; R. J. Boegman [Canada] ; R. J. Beninger ; K. Jhamandas [Canada] | Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase |
| 000E48 |
J.-A. St-Pierre [Canada] ; P. J. Bedard | Systemic administration of the NMDA receptor antagonist MK-801 potentiates circling induced by intrastriatal microinjection of dopamine |
| 000E56 |
S. A. L. Bennett [Canada] ; B. Stevenson ; W. A. Staines ; D. C. S. Roberts | Periodic acid-Schiff(PAS)-positive deposits in brain following kainic acid-induced seizures : relationships of fos induction, neuronal necrosis, reactive gliosis, and blood-brain barrier breakdown |
| 000E61 |
E. I. Miklyaeva [Canada] ; D. J. Martens ; I. Q. Whishaw | Impairments and compensatory adjustment in spontaneous movement after unilateral dopamine depletion in rats |
| 000E81 |
XUDONG WANG [Canada] ; F. Manganaro ; H. M. Schipper | A cellular stress model for the sequestration of redox-active glial in the aging and degenerating nervous system |
| 000E88 |
E. Scarr [Canada] ; D. M. Wingerchuk ; A. V. Juorio ; I. A. Paterson | The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions |
| 000E98 |
B. P. Connop [Canada] ; N. G. Rolfe ; R. J. Boegman [Canada] ; K. Jhamandas [Canada] ; R. J. Beninger | Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole |
| 000F59 |
L. Rioux [Canada] ; C. Gagnon ; D. P. Gaudin [Canada] ; T. Di Paolo ; P. J. Bedard [Canada] | A fetal nigral graft prevents behavioral supersensitivity associated with repeated injections of L-dopa in 6-OHDA rats. Correlation with D1 and D2 receptors |
| 000F78 |
L. C. Doering [Canada] | Peripheral nerve segments promote consistent long-term survival of adrenal medulla transplants in the brain |
| 000F97 |
M. L. Paul [Canada] ; A. M. Graybiel ; J.-C. David ; H. A. Robertson [Canada] | D1-like and D2-like dopamine receptors synergistically actitave rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease |
| 001013 |
R. Rivest ; S. St-Pierre ; F. B. Jolicoeur | Structure-activity studies of neurotensin on muscular rigidity and tremors induced by 6-hydroxydopamine lesions in the posterolateral hypothalamus of the rat |
| 001026 |
F. B. Jolicoeur [Canada] ; R. Rivest ; A. Drumheller | Hypokinesia, rigidity, and tremor induced by hypothalamic 6-OHDA lesions in the rat |
| 001037 |
F. B. Jolicoeur ; R. Rivest ; S. St.-Pierre ; A. Drumheller | Antiparkinson-like effects of neurotensin in 6-hydroxydopamine lesioned rats |
| 001045 |
A. Fine | Transplantation of adrenal tissue into the central nervous system |
| 001093 |
G. S. Robertson ; D. G. Herrera ; M. Dragunow ; H. A. Robertson | L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra |
| 001112 |
M. Pisa | Regional specialization of motor functions in the rat striatum: implications for the treatment of parkinsonism |
| 001132 |
J. H. Thakar ; M. N. Hassan ; J. D. Grimes | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), its metabolite cyperquat (MPP+) and energy transduction in mitochondria from rat striatum and liver |
| 001173 |
H. Kamo ; S. U. Kim ; P. L. Mcgeer ; D. H. Shin | Functional recovery in a rat model of Parkinson's disease following transplantation of cultured human sympathetic neurons |
| 001182 |
M. Takada ; T. Hattori | Collateral projections from the substantia nigra to the cingulate cortex and striatum in the rat |
